Abstract
The newly developed assay system using recombinant Leishmania amazonensis expressing enhanced green fluorescent protein (La/egfp) has been applied to the screening of Japanese marine sponges for antileishmanial activity. Bioassay-guided fractionation of an active sponge Neopetrosia sp. afforded an active compound which was identified as renieramycin A by spectroscopic analysis. It inhibited La/egfp with an IC50 value of 0.2 µg/mL.
Original language | English |
---|---|
Pages (from-to) | 55-62 |
Number of pages | 8 |
Journal | Marine Drugs |
Volume | 2 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2004 Jun |
Externally published | Yes |
Keywords
- Leishmaniasis
- Marine sponge
- Renieramycin A
ASJC Scopus subject areas
- Pharmaceutical Science
- Drug Discovery
- Pharmacology, Toxicology and Pharmaceutics (miscellaneous)